SUTRO BIOPHARMA, INC.
Biological Products, (No Diagnostic Substances) · 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080
官方登记数据
0位关注者
2003成立于
关于 SUTRO BIOPHARMA, INC.
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080
成立2003
法律形式C Corporation
状态营业中
专利253 项专利
ANTI-B7-H3 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-B7-H3 ANTIBODIES AND METHODS OF MAKING AND USING ANTI- B7-H3 ANTIBODIESWO2026165269A1 · 2026
HIGH CELL DENSITY FED-BATCH FERMENTATIONWO2026136953A3 · 2026
关键数据
法律信息
| 法定名称 | SUTRO BIOPHARMA, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1382101在 SEC EDGAR 上查看 ↗ |
| EIN | 45-2441988 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面